Source: BUSINESS WIRE

Press Release: Altravax : Research and Markets: Western Equine Encephalitis Pipeline Review, H2 2015 - 5 Companies & 3 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ww59qn/western_equine) has announced the addition of the "Western Equine Encephalitis - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Western Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mol

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michael Chambers's photo - Interim-CEO of Altravax

Interim-CEO

Michael Chambers

CEO Approval Rating

70/100

Read more